🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Genomics BioSci & Tech. Co.,Ltd. (TPE:4195)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.70
-1.15 (-8.95%)
At close: Nov 20, 2026

Genomics BioSci & Tech. Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
153.74138.3172.58253.03317107.5
Short-Term Investments
47.234.665---
Cash & Short-Term Investments
200.95172.9237.58253.03317107.5
Cash Growth
58.66%-27.23%-6.11%-20.18%194.90%-81.30%
Accounts Receivable
175.26183.71138.86116.1100.0281.75
Other Receivables
0.160.440.390.740.011.44
Receivables
175.41184.15139.25116.84100.0283.2
Inventory
230.01235.82185.4961.5154.820.99
Prepaid Expenses
20.7614.1118.0916.858.8321.92
Other Current Assets
9.3832.3934.7723.5817.4518.23
Total Current Assets
636.5639.36615.19471.82498.1251.83
Property, Plant & Equipment
625.95648.09648.43498.69373.37311.02
Long-Term Investments
208.4799.7974.65153.98237.96285.83
Other Intangible Assets
11.316.545.771.730.861.16
Long-Term Accounts Receivable
--0.64---
Long-Term Deferred Tax Assets
-----0.07
Other Long-Term Assets
24.1632.3415.687.639.443.27
Total Assets
1,5061,4261,3601,1341,120853.18

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
85.43125.6797.429.7340.4727.31
Accrued Expenses
-42.5435.428.734.527.54
Short-Term Debt
264.32250.11128.965050-
Current Portion of Long-Term Debt
61.4660.8735.414.8612.43.9
Current Portion of Leases
6.466.56.436.514.753.39
Current Income Taxes Payable
----0.58-
Current Unearned Revenue
27.6433.4443.6912.722018.89
Other Current Liabilities
77.2814.1835.4813.576.2113.57
Total Current Liabilities
522.58533.3382.77146.09168.9194.59
Long-Term Debt
298.91301.47328.89214.01153.3575.67
Long-Term Leases
10.39.37.988.248.343.58
Total Liabilities
831.79844.07719.64368.33330.6173.84

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
800724.48724.48724.48630.28578.92
Additional Paid-In Capital
95.431.0730.15131.5358.9143.76
Retained Earnings
-276.85-213.33-204.06-88.24101.8536.07
Comprehensive Income & Other
-1.38-1.87-1.84-2.25-1.9120.59
Total Common Equity
617.2510.34548.73765.51789.13679.34
Minority Interest
57.471.7291.99---
Shareholders' Equity
674.6582.07640.73765.51789.13679.34
Total Liabilities & Equity
1,5061,4261,3601,1341,120853.18

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
641.45628.25507.67283.61228.8486.53
Net Cash (Debt)
-440.5-455.35-270.08-30.5888.1720.96
Net Cash Growth
----320.57%-95.42%
Net Cash Per Share
-5.85-6.29-3.73-0.431.390.35
Filing Date Shares Outstanding
79.6972.4572.4572.4564.2960.23
Total Common Shares Outstanding
79.6972.4572.4572.4564.2960.23
Working Capital
113.92106.06232.42325.73329.19157.24
Book Value Per Share
7.747.047.5710.5712.2711.28
Tangible Book Value
605.89503.8542.96763.78788.27678.18
Tangible Book Value Per Share
7.606.957.4910.5412.2611.26
Land
-206.74206.74139.79104.76104.76
Buildings
-266.04256.36211.33144.63134.61
Machinery
-315.59234.39231.91142.81150.45
Construction In Progress
--52.590.2379.4526.25
Leasehold Improvements
-1.01----